(This is a contributed guest column. To be considered as an MJBizDaily guest columnist, please submit your request here.)
John Fraser (Photo courtesy of Dykema)
It’s no secret that the federal government’s original decision to make marijuana a Schedule 1 controlled substance was motivated by politics instead of science.
While it has taken more than 50 years, the federal government is now on the cusp of rescheduling marijuana to Schedule 3 in acknowledgement of the cannabis plant’s numerous health benefits.
Rescheduling marijuana to Schedule 3, which acknowledges the medical benefits of cannabis, starts to reconnect federal marijuana policy with science.
But while this proposed shift represents progress on federal policy, it also raises new questions at the intersection of health care, data privacy and cybersecurity.
ADVERTISEMENT
HIPAA
Read full article on Marijuana Business Daily
